Article thumbnail

Chronic hepatitis B infection and liver cancer

By CH Wong and KL Goh

Abstract

Hepatitis B virus (HBV) is one of the most well recognised human carcinogens. Since its discovery about 40 years ago, HBV has been studied extensively. This article summarises the evidence derived from various studies including epidemiological, animal model, histopathology studies and molecular genetics studies leading to the establishment of HBV as the main aetiological agent for hepatocellular carcinoma (HCC). The reduction in the incidence of childhood HCC due to mass hepatitis B vaccination in Taiwan is a dramatic demonstration of the critical aetiological role of hepatitis B in HCC. Thus it is essential for interventionalists to understand the epidemiological and pathogenesis of HCC to ensure optimal patient care

Topics: Review Article
Publisher: Department of Biomedical Imaging, Faculty of Medicine, University of Malaya, Malaysia
OAI identifier: oai:pubmedcentral.nih.gov:3097640
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles

Citations

  1. Chronic hepatitis and hepatocellular carcinoma associated with woodchuck hepatitis virus.
  2. (2000). Chronic hepatitis B virus infection in Asian countries.
  3. (2002). database [Web Page]. Available at http://wwwdep.iarc.fr/.
  4. Epidemiology of hepatocellular carcinoma.
  5. (1999). Epidemiology of primary liver cancer. Semin Liver Dis
  6. HBV integrants of hepatocellular carcinoma cell lines contain an active enhancer.
  7. Hepatitis B antigen in the liver cells in cirrhosis and hepatocellular carcinoma. Pathology (Phila)
  8. Hepatitis B antigen in the liver in hepatocellular carcinoma in Shikoku,
  9. Hepatitis B virus X protein and p53 tumor suppressor interactions in the modulation of apoptosis.
  10. Hepatitis B virus. The major etiology of hepatocellular carcinoma.
  11. Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22 707 men in Taiwan.
  12. (1984). Hepatocellular carcinoma and hepatitis B virus. Semin Liver Dis
  13. Hepatocellular carcinoma in the woodchuck model of hepatitis B virus infection.
  14. (1990). Integration of hepatitis B virus DNA and its implications for hepatocarcinogenesis.
  15. Integration of hepatitis B virus DNA into the genome of liver cells in chronic liver disease and hepatocellular carcinoma. Studies in percutaneous liver biopsies and post-mortem tissue specimens.
  16. Interrupted replication of hepatitis B virus in liver tissue of HBsAg carriers with hepatocellular carcinoma.
  17. (2004). Organization. Statistics by country or region. WHO Statistical Information System
  18. Primary liver cancer. Quadrennial review lecture.
  19. Putative role of hepatitis B virus X protein in hepatocarcinogenesis: effects on apoptosis, DNA repair, mitogen-activated protein kinase and JAK/STAT pathways.
  20. Staining methods of Australia antigen in paraffin section--detection of cytoplasmic inclusion bodies.
  21. (1998). The hepatitis B virus HBx protein inhibits caspase 3 activity.
  22. The progression of hepatitis B- and C-infections to chronic liver disease and hepatocellular carcinoma: epidemiology and pathogenesis.
  23. (1997). Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group.
  24. (1998). X-gene product of hepatitis B virus induces apoptosis in liver cells.